Skip to content

Drug interactions

Epcoritamab + Fluvoxamine

Severity: Moderate

Epcoritamab and Fluvoxamine: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Epcoritamab induces cytokine release that can transiently suppress CYP enzymes, potentially increasing exposure to fluvoxamine, a CYP1A2 and CYP2D6 substrate. The effect is greatest around the first doses and during CRS, but fluvoxamine has a wide therapeutic margin.

What this interaction means in plain words

Epcoritamab and Fluvoxamine can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Epcoritamab belongs to Oncology; Fluvoxamine belongs to Central Nervous System.

Evidence level: Low

Why it happens

Cytokine-mediated suppression of CYP enzymes may reduce fluvoxamine clearance.

What to do

Monitor for fluvoxamine adverse effects during the initial epcoritamab dosing and CRS, and adjust the dose if needed.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Epcoritamab and Fluvoxamine, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Epcoritamab with Fluvoxamine?

MediHelp rates the interaction as moderate. Epcoritamab and Fluvoxamine can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Epcoritamab induces cytokine release that can transiently suppress CYP enzymes, potentially increasing exposure to fluvoxamine, a CYP1A2 and CYP2D6 substrate. The effect is greatest around the first doses and during CRS, but fluvoxamine has a wide therapeutic margin.

How serious is the interaction between Epcoritamab and Fluvoxamine?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for fluvoxamine adverse effects during the initial epcoritamab dosing and CRS, and adjust the dose if needed.

What other medicines interact with Fluvoxamine?

MediHelp also lists interactions of Fluvoxamine with, for example, Agomelatine, Alosetron, Fezolinetant. The full list is on the Fluvoxamine page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in